33 assistant-professor-computer-science-data-"https:"-"https:"-"https:" Fellowship positions at City of Hope
Sort by
Refine Your Search
-
physiology and pathogenesis. 2) Development of novel drugs to treat MASH, diabetes, and cancer. For more information on Dr. Wendong Huang’s research, please visit here . Your qualifications should include
-
candidate, you will: · You must have experience with flow cytometry, molecular biology techniques, cell culture, microscopy, tissue processing, immunohistochemistry, immunofluorescence, data analysis
-
, the selected candidate will advance ongoing correlative studies by analyzing immune markers of response in clinical samples. For more information about Dr. Kortylewski’s lab, please visit the Kortylewski Lab
-
utilizes genetic mouse models, molecular biology, imaging and epigenetic techniques to study the cellular identity, function, remodeling, and survival of beta-cells in physiological and pathological
-
approaches developed in the lab, and develop novel cancer immunotherapies targeting metastatic cancer cells. Cancer immunotherapy is one of the most important breakthroughs in the development of cancer
-
through cutting-edge research. The laboratories of Dr. Le Xuan Truong Nguyen in the Department of Hematological Malignancies and Translational Sciences are seeking highly motivated and innovative
-
that contribute to the advancement of medical science and have a direct impact on patient outcomes. Our research focuses on a wide range of areas, including: Cancer Biology Cancer Genetics and Epigenetics
-
the opportunity to work on cutting-edge projects that contribute to the advancement of medical science and have a direct impact on patient outcomes. Your qualifications should include: · Ph.D
-
-omics data to identify therapeutic targets and biomarkers. Study cardiomyopathy across models of diabetes, cancer, and pressure overload. Collaborate in an interdisciplinary team and contribute to high
-
and its implications in autoimmune and infectious diseases. Our research is supported by NIH and industry grants and aims to translate basic T cell biology into therapeutic insights for immune-mediated